www.liposomes.ca/. /311%20Wan%20et%20al%202013.pdfCachedSimilarsiRNA formulation in the clinic (ALN-VSP) contains the first generation cationic
mct.aacrjournals.org/cgi/content/meeting_abstract/8/12. /B204A SNALP-formulated combinationof the KSP and VEGF siRNAs (referred to as
www.alnylam.com/. /complete-study-results-from-our-aln-vsp-phase-i-trial-and-extension-study-published-in-cancer-discovery/CachedSimilar30 Jan 2013 . We have published complete study results from our Phase I clinical trial with ALN
www.qps.com/. /QPS_Commercial%20Whitepaper_RNAi%20Therapeutics_Final_January%202012.pdfCachedSimilarPhase of. Development. Sirna-027. Sirna Therapeutics/Allergan. Downregulation
www.thestreet.com/. /alnylam8217s-aln-vsp-abstract-published-by-american-society-of-clinical-oncology-asco.html18 May 2011 . “We are encouraged by the data from our ALN-VSP program, as they represent
silence-therapeutics.com/. /alnylam-and-ascletis-form-strategic-collaboration-to-develop-aln-vsp-an-rnai-therapeutic-for-the-treatment-of-liver-ca. Cached12 Jul 2012 . Partnership is Focused on Developing ALN-VSP for Hepatocellular Carcinoma (
biotuesdays.com/tag/aln-vsp/Cached10 Feb 2012 . You are here: Home / Archives for ALN-VSP . the company's two lead
www.biospace.com/News/alnylam. aln-vsp-abstract/221345Cached19 May 2011 . CAMBRIDGE, Mass.----Alnylam Pharmaceuticals, Inc. , a leading RNAi
www.highbeam.com/doc/1G1-259529259.htmlCached21 Jun 2011 . Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
nextbigfuture.com/2010/. /rna-interference-success-versus-cancer.htmlCachedSimilar2 Sep 2010 . Popular Science reports that biotech company Alnylam announced in June that
www.wikinvest.com/. /Alnylam. (ALNY)/Advances_Aln-vsp_Rnai_Therapeutic_Treatment_Liver_Cancer_LeadCached6 Aug 2008 . Advances ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer, as
www.n-of-one.com/obrgreen/obr_vol8_issue2.phpCachedSimilarResearchers at multiple institutions in collaboration with Alnylam
www.drugdevelopment-technology.com/. /newsalnylam-ascletis-partner-rnai-cancersCached13 Jul 2012 . Alnylam Pharmaceuticals and Ascletis Pharmaceuticals have partnered to
www.empr.com/phase-1-study-of-aln-vsp-for-liver. /130096/Cached3 Apr 2009 . Alnylam Pharmaceuticals announced that it has initiated a Phase 1 human
ALN-VSP is composed of two siRNA molecules, targeting VEGF and Eg5 (KSP),
www.inspire.com/groups/lung-cancer-survivors/. /aln-vsp/CachedDear friends, Is there any information about this new one? Thank you, Ann .
www.cnbc.com/id/100736733Cached14 May 2013 . ALN-VSP, which is a systemically delivered RNAi therapeutic for the treatment of
rnaitherapeutics.blogspot.com/. /tekmira-and-alnylam-in-binding.htmlCachedSimilar9 Aug 2013 . As a reminder, Tekmira was to earn the milestone for enabling Alnylam's ALN-
aln-vsp.com/Cachedaln-vsp.com. Find the best information and most relevant links on all topics
www.drugs.com/. /alnylam-s-aln-vsp-abstract-published-american-society-clinical-oncology-asco-9452.htmlCached20 May 2010 . “We are encouraged by the results we have seen with ALN-VSP in this Phase I
www.xconomy.com/. /alnylam-to-pay-tekmira-65m-to-settle-rnai-delivery-dispute/CachedSimilar12 Nov 2012 . . plus another $5 million payment to Tekmira when clinical trials of the liver
www.biotechnologyevents.com/node/3128CachedAlnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
www.ncbi.nlm.nih.gov/pubmed/23358650Similar28 Jan 2013 . To examine the activity and safety of LNP-formulated siRNAs in humans, we
www.pharmiweb.com/pressreleases/pressrel.asp?. Cached31 Mar 2011 . ALN-VSP was administered to over 40 patients at doses ranging from 0.1 to 1.5
www.larvol.com/. /VEGF%20Report%20Issue%204%20(sample).pdfCachedSimilar(PR-USA) [ALN-VSP / Alnylam; Robust anti-tumor efficacy, significant . overall
www.abstractsonline.com/. /ViewAbstract.aspx?. CachedPresentation Title: Development of ALN-VSP: An RNAi therapeutic for solid
www.tudou.com/home/diary_v4834021.htmlCached2010年12月2日 . Now,《时代周刊》评选出七大最糟糕的发明- Qzone日志, 阿尔尼拉姆company plans
www.sciencedaily.com/releases/2013/02/130211090837.htmCachedSimilar11 Feb 2013 . This system takes the form of a novel drug (ALN-VSP) made up of RNAi
www.silencejournal.com/content/1/1/14CachedSimilarFinally, ALN-VSP builds on data from animal models in which five transcripts
www.benzinga.com/. /alnylam-completes-aln-vsp-phase-i-trial-in-patients-with-liver-cancerCached1 Aug 2011 . Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that it has
www.worldpharmatoday.com/. /alnylam-and-ascletis-collaborate-to-develop-aln-vsp-for-liver-cancers-in-chinaCached13 Jul 2012 . Under the agreement, Ascletis gained an exclusive license from Alnylam to
www.marketwired.com/. /tekmira-partner-alnylam-presents-aln-vsp-preliminary-phase-1-clinical-trial-results-tsx-tkm-1271922.htmCached7 Jun 2010 . ALN-VSP utilizes Tekmira's lipid nanoparticle technology (stable nucleic acid-
Alnylam Pharmaceuticals ALN-RSV01 Phase III RSV nucleocapsid /lungs
www.4-traders.com/ALNYLAM. /ALNYLAM-PHARM--Alnylams-ALN-VSP-Abstract-Published-by-American-Society-of-Clinical-Oncology. Cached18 May 2011 . "We are encouraged by the data from our ALN-VSP program, as they represent
www.reuters.com/. /05/. /idUS241647+18-May-2011+BW20110518Cached18 May 2011 . “We are encouraged by the data from our ALN-VSP program, as they represent
www.cancercommons.org/tag/aln-vsp/CachedSimilarFirst-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and
www.news-medical.net/. /Alnylam-announces-results-from-ALN-VSP-Phase-I-study-on-liver-cancers.aspxCachedSimilar5 Jun 2012 . Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company,
www.tekmira.com/pipeline/partnered-products.phpCachedSimilarAlnylam currently has three LNP-based products in clinical development: ALN-
www.ribolia.com/en/rnai/index.aspx?BasicClassId=565&HeadID. CachedSimilarUnder the agreement, Ascletis gained an exclusive license from Alnylam to
clinicaltrials.pharmaceutical-business-review.com/. /alnylam-pharma-concludes-patient-recruitment-in-aln-vsp-phase-i-trial-Cached1 Apr 2011 . Alnylam Pharmaceuticals has concluded patient recruitment in a multi-center,
www.bio.org/alnylam-presents-data-its-phase-i-extension-study-aln-vsp-rnai-therapeutic-treatment-liver-cancers-aCached4 Jun 2012 . Alnylam Presents Data from its Phase I Extension Study with ALN-VSP, an RNAi
www.streetinsider.com/. /Alnylam+(ALNY). ALN-VSP. /8041983.htmlCachedSimilar30 Jan 2013 . Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced the publication of
www.lifesciencesbc.ca/News/Member_Press. /pr04030901.aspCached3 Apr 2009 . Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients With Liver
trs.scivee.tv/node/2921Cached2 Sep 2010 . Iva Toudjarska1, Tim Buck1, Joshua Brodsky1, Akin Akinc1, Tim Racie1, Dinah
dgidb.genome.wustl.edu/drug_claims/TTD/DCL001139CachedCitation: Update of TTD: Therapeutic Target Database. Zhu F, Han BC, . , Zheng
It has completed a Phase 1 trial of ALN-VSP, an RNAi therapeutic for solid
www.thelifesciencesreport.com/cs/user/download/co_file/4169CachedSimilarLNP-formulated siRNAs tested by partner Alnylam, like ALN-VSP. (tested at .
www.the-scientist.com/?articles.view/articleNo/35629/title/. CachedSimilar20 May 2013 . Known as ALN-VSP, the drug passed through Phase 1 trials earlier this year,
www.dailyfinance.com/. /alnylam-and-tekmira-restructure-relationship-and-s/Cached12 Nov 2012 . Further, Alnylam has elected to buy-down certain future potential milestone and
her2support.org/vbulletin/showthread.php?t=47572CachedAlnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today